66 results on '"Xu-Hui, Hui"'
Search Results
52. [Expression of CXCR4 and VEGF in hemangioblastomas of the central nervous system and its relation to tumor angiogenesis]
- Author
-
Tao, Wang, Xu-Hui, Hui, Liang-Xue, Zhou, Yan, Ju, Hong-Tao, Rong, and Qiao, Zhang
- Subjects
Adult ,Male ,Vascular Endothelial Growth Factor A ,Receptors, CXCR4 ,Young Adult ,Adolescent ,Neovascularization, Pathologic ,Brain Neoplasms ,Humans ,Female ,Middle Aged ,Aged ,Hemangioblastoma - Abstract
To evaluate the relationships of CXCR4 (chemokine stromal cell-drived factor-1 receptor) and VEGF (vaseular endothelial growth factor) expression to tumor angiogenesis in hemangioblastomas of the central nervous system.The protein expressions of CXCR4 and VEGF were detected by SP immunohistochemical staining in 40 hemangioblastomas. The endothelial cells of blood vessels within the tumor were labeled by CD34, then the microvessel density (MVD) was calculated.Total positive expression rates of CXCR4 and VEGF were 95% (38/40) and 85% (34/40) respectively. The expression rates of CXCR4 and VEGF were found positive obviously in hemangioblastomas compared with the normal cerebellar tissues (P0.01). CXCR4 expression was located in the nucleus of tumor stromal cells. VEGF expression was located in the cytoplasm and membrane of tumor stromal cells and some endothelial cells. VEGF has significant positive correlation with the expression level of CXCR4 (r = 0.704, P0.001). MVD also has significant positive correlation with the expression level of CXCR4 and VEGF (P0.001). But there is no significant difference between the cystic and solid tumors, VHL disease and sporadic disease on the expression level of CXCR4, VEGF and MVD (P0.05).CXCR4 and VEGF may collaborate to induce angiogenesis in hemangioblastomas.
- Published
- 2010
53. Associations between NBS1 Polymorphisms and Colorectal Cancer in Chinese Population
- Author
-
Li, Jing-Tao, primary, Zhong, Bao-Yuan, additional, Xu, Hui-Hui, additional, Qiao, Sheng-Yan, additional, Wang, Gui, additional, Huang, Jing, additional, Fan, Hui-Zhen, additional, and Zhao, Hong-Chuan, additional
- Published
- 2015
- Full Text
- View/download PDF
54. Microsurgery via modified far-lateral approach for giant dumbbell-shaped jugular foramen tumors
- Author
-
Yue-Kang Zhang, Hai-Feng Chen, Xu-Hui Hui, Lu Jia, and Lin-Bo Zou
- Subjects
Adult ,Male ,medicine.medical_specialty ,Microsurgery ,medicine.medical_treatment ,Vertebral artery ,Meningioma ,medicine.artery ,Temporal bone ,medicine ,Humans ,Hearing Loss ,Retrospective Studies ,Neurilemoma ,Palsy ,business.industry ,Glomus Jugulare Tumor ,Recovery of Function ,Middle Aged ,medicine.disease ,Facial nerve ,Magnetic Resonance Imaging ,Cranial Nerve Diseases ,Surgery ,Radiography ,medicine.anatomical_structure ,Oncology ,Female ,business ,Jugular foramen ,Neurilemmoma ,Follow-Up Studies - Abstract
Background and objective During the resection of jugular foramen tumors via the basic far lateral approach, the jugular foramen tumor area as well as its adjacent structures, especially the intracranial part, can be better exposed, which avoids stripping of the petrous part of temporal bone and displacement of facial nerve, and protects the patient's hearing from damage. However, when applied in tumors developed from ventral to the brain stem and middle fossa, with extracranial tumors, this surgical approach seems to be inadequate and limited. This study was to explore the microsurgical technique and clinical value for treating giant dumbbell-shaped tumors at jugular foramen (JF) via a modified far lateral approach. Methods A retrospective analysis was performed in 16 patients with huge dumbbell-shaped tumors at JF which were removed through the modified far lateral approach (suboccipital transjugular-jugular tubercle-jugular process) between January 2001 and December 2008. The process of operation, and pre-and postoperative clinical data were included in the analysis. Results Gross total tumor removal was achieved in 14 cases, subtotal removal in 1 case, and partial removal in 1 case. Follow-up examinations in most patients demonstrated that the patient with an obvious preoperative deficit had a good recovery. During the follow-up from three months to seven years, 10 (76.9%) cases with lower cranial nerve involvement showed obvious improvement of symptom after operation, 8 (80.0%) cases with facial palsy obtained various degrees of alleviation, and 7 (77.8%) cases with hearing impairment at different levels restored hearing. Two patients developed new lower cranial nerve palsies after operation, and underwent functional rehabilitation in the three-month follow-up. Conclusions Modified far lateral approach is helpful for removing the huge tumors at JF, especially for tumors extending to the petroclival region ventral part of pontomedullary junction. It has a higher rate of total resection, preoperative cranial nerve function impairment is expected to restore, and also has the advantage of protecting the facial nerve, labyrinth and vertebral artery structure from unnecessary damage.
- Published
- 2010
55. [Expression of CD147 and MMP-2 in human gliomas and its correlations with prognosis]
- Author
-
Hao, Li, Jing, Chen, Min, He, Xu-hui, Hui, Bo-wen, Cai, and Yang, Li
- Subjects
Adult ,Gene Expression Regulation, Neoplastic ,Male ,Young Adult ,Basigin ,Humans ,Matrix Metalloproteinase 2 ,Female ,Glioma ,RNA, Messenger ,Middle Aged ,Prognosis ,Aged - Abstract
To investigate the expressions of CD147 and MMP-2 in human gliomas and to study the relationship between their expression and prognosis.Immunohistochemistry SP methods were applied to detect the expression of CD147 and MMP-2 in 50 cases of gliomas and RT-PCR also applied to analyze the expression level of CD147 mRNA. The relationship between the expression level and the glioma prognosis were analyzed statistically depends on the follow-up investigation of the disease development.The positive rates of CD147 and MMP-2 in human gliomas were 72. 0% and 78. 0%, and coexpression of CD147 and MMP-2 in gliomas was 70. 0%. CD147 protein was positively correlated with the expression of MMP-2 protein (r =0. 737, P0. 01). CD147 mRNA expression was also detected in low and high grade gliomas by RT-PCR, but their expression levels were obviously enhanced in high grade gliomas. There was a significant difference in each grade gliomas. The higher expression of CD147, the shorter survival time of the patients. The variations were significant statistically.There was positive correlation between the expressions of CD147, MMP-2 in human gliomas and the degree of malignancy and prognosis. CD147 and MMP-2 may be a prognostic factor of human gliomas and targets for chemotherapeutical strategies.
- Published
- 2007
56. [An experimental research on tumor metastasis treated by chicken homologous matrix metalloproteinase-2 vaccine combined with low-dose cisplatin]
- Author
-
Jing, Chen, Xu-hui, Hui, Hao, Li, Bo-wen, Cai, Wei, Wang, and Bin, Zhu
- Subjects
Mice, Inbred BALB C ,Immunoconjugates ,Neovascularization, Pathologic ,Apoptosis ,Cancer Vaccines ,Mice ,Drug Resistance, Neoplasm ,Cell Line, Tumor ,Sequence Homology, Nucleic Acid ,Vaccines, DNA ,Animals ,Matrix Metalloproteinase 2 ,Female ,Cisplatin ,Neoplasm Metastasis ,Chickens ,Lung ,Autoantibodies - Abstract
To evaluate the cooperating effect on whether the chicken homologous matrix metalloproteinase-2 (c-MMP-2) vaccine combined with low-dose cisplatin (DDP) can enhance the treatment efficacy of tumor metastasis.The eukaryotic expression plasmid encoding chicken homologous MMP-2 was constructed by recombinant DNA technique. In this experiment, the lung metastasis model of murine colon adenocarcinoma (C26) was established in 6- to 8- weeks of age female BALB/c mice, and then treated with 0.9% NaCl solution (NS), DDP, c-MMP-2, or c-MMP-2 combined DDP. The number of tumor metastasis nodules on murine lung surface was counted and the lungs were weighed after the completion of above treatments. The tumor microvessel density (MVD) and cell apoptosis were evaluated by immunohistochemical and TUNEL methods. The titer and type of autoantibodies against MMP-2 in serum of mice were evaluated by enzyme-linked immunosorbent assay (ELISA).Compared with three other control groups, the combined treatment group significantly decreased the number of tumor metastasis nodules on lung surface and markedly the weight of murine lungs. The immunohistochemical analysis of tumor demonstrated a decreased MVD and a higher apoptosis cell rate happening to the combined treatment group. Autoantibodies against MMP-2 in serum of mice were, by ELISA, found in c-MMP-2 group and c-MMP-2 combined DDP group.The antitumor effect of DDP can be potentiated by c-MMP-2. Thus the combination of c-MMP-2 and DDP results in an additive effect on the treatment of tumor metastasis.
- Published
- 2007
57. HLA‐G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer
- Author
-
Lin, Aifen, primary, Zhang, Xia, additional, Xu, Hui‐Hui, additional, Xu, Dan‐Ping, additional, Ruan, Yan‐Yun, additional, and Yan, Wei‐Hua, additional
- Published
- 2011
- Full Text
- View/download PDF
58. Influence of Working Memory Capacity on Processing English Temporary Syntactic Ambiguity Sentences for Chinese-English Bilinguals
- Author
-
CHEN, Bao-Guo, primary and XU, Hui-Hui, additional
- Published
- 2010
- Full Text
- View/download PDF
59. Grid resource scheduling algorithm based on QoS guided GA
- Author
-
Shi, Lei, primary and Xu, Hui-hui, additional
- Published
- 2009
- Full Text
- View/download PDF
60. Timing of operation for poor-grade aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.
- Author
-
Qiao Zhang, Lu Ma, Yi Liu, Min He, Hong Sun, Xiang Wang, Yuan Fang, Xu-hui Hui, and Chao You
- Subjects
HEMORRHAGE ,INTRACRANIAL aneurysm ruptures ,MORTALITY ,PROGNOSIS ,ARTERIAL injuries - Abstract
Background: Subarachnoid hemorrhage is a common and dangerous disease with an unfavorable prognosis. Patients with poor-grade subarachnoid hemorrhage (Hunt & Hess Grades 4-5) are unconscious on admission. Because of the high mortality and disability rate associated with poor-grade subarachnoid hemorrhage, it is often treated conservatively. Timing of surgery for poor-grade aneurysmal subarachnoid hemorrhage is still controversial, therefore this study aims to identify the optimal time to operate on patients admitted in poor clinical condition. Methods/design: Ninety-nine patients meeting the inclusion criteria were randomly assigned into three treatment groups. The early surgery group received operation within 3 days after onset of subarachnoid hemorrhage (day of SAH = day 1); the intermediate surgery group received operation from days 4 to 7, and surgery was performed on the late surgery group after day 7. Follow-up was performed 1, 3, and 6 months after aneurysm clipping. Primary indicators of outcome included the Extended Glasgow Outcome Scale and the Modified Rankin Scale, while secondary indicators of outcome were assessed using the Barthel Index and mortality. Discussion: This is the first prospective, single-center, observer-blinded, randomized controlled trial to elucidate optimal timing for surgery in poor-grade subarachnoid hemorrhage patients. The results of this study will be used to direct decisions of surgical intervention in poor-grade subarachnoid hemorrhage, thus improving clinical outcomes for patients. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
61. Antibacterial activity of genetic engineering tachyplesin against Staphylococcus aureus and effect of treatment in murine model of infection.
- Author
-
HAN Dong, FENG Xin, HAN Wen-yu, HAN Jun-you, HUANG Pan-pan, HE Bo-ping, XU Hui-hui, LEI Lian-cheng, and SUN Chang-jiang
- Abstract
The article presents information on a study related to the antibacterial activity of genetically engineered tachyplesin against Staphylococcus aureus and the effect of treatment in murine model of infection. It informs that tachyplesin I (TP I) displayed broad-spectrum antibacterial activity against 13 genus 61 strains bacteria. It further informs that the tachyplesin have a therapeutic effect in a mouse skin infection model.
- Published
- 2013
62. Von Hippel-Lindau disease manifesting disseminated leptomeningeal hemangioblastomatosis: surgery or medication?
- Author
-
Qiao zhang, Lu Ma, Wen-yan Li, Jing Chen, Yan Ju, and Xu-hui Hui
- Subjects
DISEASE remission ,MENINGEAL cancer ,RARE diseases ,BIOPSY ,CLINICAL pathology - Abstract
We report the case of a 46-year-old man with von Hippel-Lindau (VHL) disease, manifesting disseminated leptomeningeal hemangioblastomatosis. The patient initially presented with a solitary hemangioblastoma in the right cerebellum. Later, he was diagnosed with VHL disease and underwent several surgical procedures in the following 14 years. But the prognosis was poor. Recently, the hemangioblastomatosis disseminated along leptomeninges involving both brain and spine. We aim to analyze the possible reason for the leptomeninges dissemination, discuss the imaging characteristics of this rare disease with ominous manifestation and propose the optimal strategy for treatment. We think the optimal treatment strategy should be surgical biopsy and surgical decompression. A long-term follow-up is inevitable. Antiangiogenic medication might be the hope for remission of this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
63. Experience of microsurgical treatment of brainstem cavernomas: Report of 37 cases.
- Author
-
Hao Li, Yan Ju, Bo-wen Cai, Jing Chen, Chao You, and Xu-hui Hui
- Subjects
BRAIN stem diseases ,MICROSURGERY ,MORTALITY ,OPERATIVE surgery ,CENTRAL nervous system diseases - Abstract
Background: Cavernomas are rare in the brainstem and account for 18-35% of central nervous cavernomas and can cause recurrent hemorrhages,devastating neurological deficits and mortality. Objectives: To summarize the experience of microsurgical treatment of brainstem cavernomas and to investigate curative effect of microsurgical treatment of brainstem cavernomas. Materials and Methods: A retrospective analysis clinical data of 37 patients with brainstem cavernomas seen between 2003 and 2007. The analysis included age distribution, hemorrhage rates, clinical presentation, location of the lesions, and preoperative and postoperative Karnofsky Performance Scale (KPS) scores. The surgical indications, the timing of surgery and the surgical techniques were also assessed. Results: All the 37 patients received microsurgical resections, there was no surgery-related mortality. Histopathological examination confirmed the diagnosis of cavernoma. Postoperatively, 20 patients had functional improvement, 15 patients had no change in the neurological status, and two patients deteriorated. Early surgery was associated with better outcomes. Mean followed up period was 21.5 months (range 6-36 months). During the follow-up 20 patients had resumed activities of daily living (KPS scores of 90-100), 10 patients were able to self-care with some efforts (KPS scores of 70-80), five patients needed considerable assistance (KPS score of 50-60) and two patients suffered hemiparesis (KPS scores of 40). None of the patient had recurrent hemorrhage. Conclusions: Brainstem cavernomas can safely be resected. Successful resection of brainstem cavernomas can be achived by optimal surgical approaches, feasible entry zone and meticulous microsurgical techniques. The goal of surgical intervention should be the total resection of the lesion without any deteriorative in the neurological deficits. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
64. The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation.
- Author
-
Yu JH, Yuan HB, Yan ZY, Zhang X, and Xu HH
- Subjects
- Humans, Female, Middle Aged, Prognosis, Adult, Aged, Kaplan-Meier Estimate, Uterine Cervical Neoplasms diagnosis, Uterine Cervical Neoplasms mortality, Uterine Cervical Neoplasms blood, Membrane Cofactor Protein, Biomarkers, Tumor blood
- Abstract
Background: CD46 has been revealed to be a key factor in malignant transformation and cancer treatment. However, the clinical significance of CD46 in cervical cancer remains unclear, and this study aimed to evaluate its role in cervical cancer diagnosis and prognosis evaluation., Methods: A total of 180 patients with an initial diagnosis of cervical cancer were enrolled at Taizhou Hospital of Zhejiang Province, China. The plasma levels of soluble CD46 (sCD46) and the expression of membrane-bound CD46 (mCD46) were detected by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry (IHC), respectively., Results: CD46 was found to be significantly upregulated in cervical cancer tissues vs. normal tissues, while no CD46 staining was detected in paired adjacent noncancerous tissues. CD46 staining was more pronounced in cancer cells than in stromal cells in situ (in tissues). Moreover, the plasma levels of sCD46 were able to some extent discriminate between cancer patients and healthy women (AUC=0.6847, 95% CI:0.6152-0.7541). Analysis of Kaplan-Meier survival curves revealed that patients with low CD46 expression had slightly longer overall survival (OS) than patients with high CD46 expression in the tumor microenvironment, but no significant difference. Univariate Cox regression analysis revealed that CD46 ( P =0.034) is an independent risk factor for OS in cervical cancer patients., Conclusion: The present study demonstrated that cervical cancer patients exhibit aberrant expression of CD46, which is closely associated with a poor prognosis, suggesting that CD46 plays a key role in promoting cervical carcinogenesis and that CD46 could serve as a promising potential target for precision therapy for cervical cancer., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Yu, Yuan, Yan, Zhang and Xu.)
- Published
- 2024
- Full Text
- View/download PDF
65. [Spectral Evidence of In-Situ Regulatory Mechanisms on Chemical Speciation of Lead/Cadmium Affected by Dissolved Organic Matter Extracted from Rhizosphere Loess of Calendula Officinalis Seedling].
- Author
-
Fan CH, Xu HH, and Zhang YC
- Subjects
- Cadmium, Lead, Seedlings, Soil, Soil Pollutants, Spectroscopy, Fourier Transform Infrared, Calendula, Rhizosphere
- Abstract
The various characteristics of DOM have great impact on the transformation process of contaminants in soil due to the generation of the feedback regulation in cycles of plant, Rhizosphere soil and environmental contaminants. Currently, more attention was paid on contaminants behaviors of adsorption, transformation, accumulation and detoxification than DOM derived from Rhizosphere soil. The chemical speciation of lead/cadmium and growth efficiency related variations were revealed in the growth process of Calendula officinalis seedlings, and the spectral characteristics of DOM in Rhizosphere loess were discussed with UV, FT-IR and 3D-EEMs spectra. The results showed: the dominant contents of lead/cadmium are in residual and exchangeable speciation, and the exchangeable contents increase greatly after the growth of Calendula officinalis seedlings. It causes negative effects on the height and emergency rate of Calendula officinalis seedlings with lead/cadmium, and the Calendula officinalis is able to positively improve loess characteristics. The root of Calendula officinalis appears to be longer, thinner and flexuous. The maximum absorption band of DOM in UV spectra locates in 200~240 nm, and the sharper and greater intensity of peaks can be detected under lead/cadmium stress. The absorption peaks in FT-IR spectra move from 3 444 and 1 637 to 3 440 and 1 645 cm-1, respectively, indicating the combination effects between metal ions and functional groups of—OH and CO. The dominant fluorescence peaks of DOM are found to be aroundλex/em=240/430, described as fulvic-acid like components, and metals in loess affect more on peaks intensity than locations. The characteristics of DOM in Rhizosphere loess of Calendula officinalis seedlings contain much micro-eco-environmental information, and the spectral approaches are efficient to reveal the relationship between DOM and chemical speciation of lead/cadmium.
- Published
- 2016
66. Expression of Nemo-like kinase was increased and negatively correlated with the expression of TCF4 in lung cancers.
- Author
-
Zhang XW, Chen SY, Xue DW, Xu HH, Yang LH, Xu HT, and Wang EH
- Subjects
- Adult, Aged, Aged, 80 and over, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors analysis, Carcinoma, Non-Small-Cell Lung metabolism, Female, Humans, Immunohistochemistry, Intracellular Signaling Peptides and Proteins analysis, Lung Neoplasms metabolism, Male, Middle Aged, Protein Serine-Threonine Kinases analysis, Transcription Factor 4, Transcription Factors analysis, beta Catenin metabolism, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors biosynthesis, Biomarkers, Tumor analysis, Carcinoma, Non-Small-Cell Lung pathology, Intracellular Signaling Peptides and Proteins biosynthesis, Lung Neoplasms pathology, Protein Serine-Threonine Kinases biosynthesis, Transcription Factors biosynthesis
- Abstract
Nemo-like kinase (NLK), as a mitogen activated protein kinase (MAPK)-like kinase, is involved in the development of several human cancers. In this study, we explored the expression of NLK in lung squamous cell carcinoma (SCC) and adenocarcinoma tissues, and investigated the associations among NLK, β-catenin, T-cell factor 4 (TCF4), and the clinicopathological factors of lung cancers. The expressions of NLK, β-catenin, TCF4 were examined in 109 cases of lung cancers using immunohistochemistry method. The expression of NLK was observed in the nuclei of lung cancer tissues, and was significantly higher in lung cancer tissues than that in corresponding normal lung tissues (t = 21.636, n = 109, P < 0.001). The high expression of NLK was found in 45 cases of lung SCCs (45/49, 91.84%), which was much more than that in adenocarcinomas (38/60, 63.33%) (P = 0.001). Furthermore, the high expression of NLK was negatively correlated with TCF4 expression and positively correlated with the membranous expression of β-catenin. In conclusion, the present study demonstrated that the expression of NLK was localized in nucleus and significantly increased in lung cancers. The expression of NLK was negatively correlated with TCF4 expression and positively correlated with β-catenin membranous expression in lung cancers.
- Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.